ANWAR ISMAIL: Open Payments
NPI 1679501712 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 29 payments from 9 companies in 2025. Trend: 2023 $716 · 2024 $504 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $174 |
| Alkermes, Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Luye Pharma (USA) Ltd. | 2 | $31 |
| Lundbeck LLC | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: COBENFY, LYBALVI, AUSTEDO XR, CAPLYTA, INVEGA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, FANAPT.
Industry payments across TX — which companies pay providers there.
